Wilson Miller
McGill University
H-index: 90
North America-Canada
Top articles of Wilson Miller
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Tunable PhenoCycler imaging of the murine pre-clinical tumour microenvironments | Cell & Bioscience | Madelyn J Abraham Christophe Goncalves Paige McCallum Vrinda Gupta Samuel EJ Preston | 2024/2/4 |
Author Correction: Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial | Nature Medicine | Bertrand Routy John G Lenehan Wilson H Miller Jr Rahima Jamal Meriem Messaoudene | 2024/2 |
Inhibiting the MNK1/2-eIF4E axis impairs melanoma phenotype switching and potentiates antitumor immune responses | The Journal of clinical investigation | Fan Huang Christophe Gonçalves Margarita Bartish Joelle Rémy-Sarrazin Mark E Issa | 2021/4/15 |
Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial | Nature Medicine | Jayesh Desai Guzman Alonso Se Hyun Kim Andres Cervantes Thomas Karasic | 2024/1 |
MNK1/2 inhibition limits oncogenicity and metastasis of KIT-mutant melanoma | The Journal of clinical investigation | Yao Zhan Jun Guo William Yang Christophe Goncalves Tomasz Rzymski | 2017/11/1 |
CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial | Investigational New Drugs | Andrew J Armstrong Ravit Geva Hyun Cheol Chung Charlotte Lemech Wilson H Miller Jr | 2024/2/7 |
Inhibition of the MNK1/2–eIF4E Axis Augments Palbociclib-Mediated Antitumor Activity in Melanoma and Breast Cancer | Molecular Cancer Therapeutics | Sathyen A Prabhu Omar Moussa Christophe Gonçalves Judith H LaPierre Hsiang Chou | 2023/2/1 |
Peroxisome disruption alters lipid metabolism and potentiates antitumor response with MAPK-targeted therapy in melanoma | The Journal of Clinical Investigation | Fan Huang Feiyang Cai Michael S Dahabieh Kshemaka Gunawardena Ali Talebi | 2023/10/16 |
Assessing skin cancer risk factors, sun safety behaviors and melanoma concern in Atlantic Canada: a comprehensive survey study | François Lagacé Bibi Nuzha Noorah Santina Conte Lorena Alexandra Mija Jasmine Chang | 2023/7/25 | |
Phase 1 trial of the anti-LAG3 antibody favezelimab plus pembrolizumab in advanced gastric cancer. | Sun Young Rha Wilson H Miller María José de Miguel Seock-Ah Im Iwona Lugowska | 2023/2/1 | |
Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19 | JAMA oncology | Shuchi Gulati Chih-Yuan Hsu Surbhi Shah Pankil K Shah Rebecca Zon | 2023/10/1 |
Belzutifan plus lenvatinib for patients (pts) with advanced clear cell renal cell carcinoma (ccRCC) after progression on a PD-1/L1 and VEGF inhibitor: Preliminary results of … | Laurence Albiges Katy Beckermann Wilson H Miller Jeffrey C Goh Pablo Gajate | 2023/6/1 | |
The impact of lag time to cancer diagnosis and treatment on clinical outcomes prior to the COVID-19 pandemic: A scoping review of systematic reviews and meta-analyses | Parker Tope Eliya Farah Rami Ali Mariam El-Zein Wilson H Miller | 2023/1/31 | |
Identification of p-eIF4E as a new regulator of regulatory T-cell activity | The Journal of Immunology | François Santinon Theodoros Papadopoulos Meagan-Helen Henderson-Berg Christophe Gonçalves Madelyn Abrahams | 2023/5/1 |
Two Cases of Durable and Deep Responses to Immune Checkpoint Inhibition-Refractory Metastatic Melanoma after Addition of Camu Camu Prebiotic | Current Oncology | Steph A Pang Arielle Elkrief Mariana Pilon Capella Wilson H Miller Jr | 2023/8/25 |
Abstract B130: Phase 1 study of Zanidatamab Zovodotin (ZW49): Safety Profile and Recommended Dose (RD) in patients with Human Epidermal Growth Factor 2 (HER2)-positive solid … | NaN | Do-Youn Oh Philippe L Bedard Keun-Wook Lee Hyo Sook Han Yoon-Koo Kang | 2023 |
Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 keynote‐158 study | Cancer | Do‐Youn Oh Alain Algazi Jaume Capdevila Federico Longo Wilson Miller Jr | 2023/4/15 |
Abstract A035: Comparing the clinical and genomic landscapes of acral, mucosal, and cutaneous metastatic melanomas treated with immune checkpoint inhibitors | Cancer Immunology Research | Sadaf Solati April AN Rose Anna Spreafico Adrian Sacher Denis Yahiaoui | 2023/12/1 |
Single-Agent Divarasib (GDC-6036) in Solid Tumors with a KRAS G12C Mutation | New England Journal of Medicine | Adrian Sacher Patricia LoRusso Manish R Patel Wilson H Miller Jr Elena Garralda | 2023/8/24 |
Interplay of immunosuppression and immunotherapy among patients with cancer and COVID-19 | JAMA oncology | Ziad Bakouny Chris Labaki Punita Grover Joy Awosika Shuchi Gulati | 2023/1/1 |
Co-Authors
